Biotech, Clinical Trials, Industry, Research and Development
April 21, 2020
Via: Biopharma DiveCara’s hypothesis in developing Korsuva was that by acting on opioid receptors, the experimental drug could provide relief from itching without leading to addiction. Rather than stimulating the mu-opioid receptor, like morphine and other pain drugs with addictive potential, Korsuva […]
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
August 30, 2023
September 19, 2023